Provided by Tiger Fintech (Singapore) Pte. Ltd.

Post-Pandemic Stocks

972.603
-4.817-0.49%
Number of Gainers:2
Number of Losers:16
Number of Flat:- -
PE:- -
High:979.553
Open:977.343
Low:962.881
Close:977.420
Loading ...

CSPC Pharmaceutical Gets China Nod for Registration of Anemia Drug

MT Newswires Live
·
Yesterday

CSPC Pharmaceutical Group Ltd. Secures Drug Registration Approval for Cobamamide Capsules in China

Reuters
·
Yesterday

CSPC Pharmaceutical - Cobamamide Capsules Obtain Drug Registration Approval From Nmpa

THOMSON REUTERS
·
Yesterday

Sino Biopharm Presents Lung Cancer Drug Trial Data at US Oncology Conference

MT Newswires Live
·
Yesterday

BRIEF-Tong REN Tang Technologies Announces Resignation Of Di Shu Bing As Chairman

Reuters
·
Yesterday

Tong Ren Tang Technologies Co Ltd - Resignation of Di Shu Bing as Chairman of Board

THOMSON REUTERS
·
Yesterday

China Traditional Chinese Medicine Holdings Co. Limited Announces Special Dividend of HK8.30 Cents and Final Dividend of HK0.35 Cent Per Share

Reuters
·
04 Jun

BUZZ-Sagimet soars as oral acne drug aces late-stage trial in China

Reuters
·
04 Jun

Sagimet Biosciences Shares Jump 52% Premarket After Oral Acne Drug With Partner Ascletis Met the Main Goals in a Late-Stage Trial

THOMSON REUTERS
·
04 Jun

Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat in Treating Moderate-to-Severe Acne

Reuters
·
04 Jun

Ascletis Pharma Announces Successful Phase III Trial of Denifanstat, a Groundbreaking Oral FASN Inhibitor for Acne Treatment

Reuters
·
04 Jun

Ascletis Announces Phase Iii Trial of Denifanstat (Asc40), a First-in-Class, Once-Daily Oral Fasn Inhibitor for Acne, Meets All Endpoints

THOMSON REUTERS
·
04 Jun

Ascletis Pharma Inc - Announces Phase Iii Trial of Denifanstat Meets All Endpoints

THOMSON REUTERS
·
04 Jun

Sino Biopharm Presents Lung Cancer Study Data at American Oncology Conference

MT Newswires Live
·
03 Jun

CSPC Pharmaceutical Group Announces Breakthrough Therapy Designation for JMT101 in Advanced Colorectal Cancer Treatment

Reuters
·
02 Jun

Fosun Pharma's Respiratory Drug Receives Clinical Trial Approval for COPD Treatment in China

MT Newswires Live
·
02 Jun

CSPC Pharmaceutical - Jmt101 Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS
·
02 Jun

CSPC Pharmaceutical Group May Benefit From Higher Success Odds of 'SYS6010' -- Market Talk

Dow Jones
·
02 Jun

Ascletis Pharma Faces Legal Setback with Seven-Year Exclusion Order for ASC41 and ASC43F Drugs

Reuters
·
30 May

Fosun Pharmaceutical Gets Chinese Regulatory Approval for Breast Cancer Drug; Shares Up 4%

MT Newswires Live
·
30 May